Qingdao Baheal Medical INC. (SHE: 301015)

China flag China · Delayed Price · Currency is CNY
22.64
-0.33 (-1.44%)
Sep 9, 2024, 1:51 PM CST
0.58%
Market Cap 12.07B
Revenue (ttm) 7.56B
Net Income (ttm) 656.31M
Shares Out 525.61M
EPS (ttm) 1.23
PE Ratio 18.81
Forward PE 14.11
Dividend 0.76 (3.32%)
Ex-Dividend Date May 29, 2024
Volume 1,802,619
Open 23.58
Previous Close 22.97
Day's Range 22.60 - 23.58
52-Week Range 20.78 - 43.50
Beta 0.36
Analysts n/a
Price Target n/a
Earnings Date Oct 28, 2024

About Qingdao Baheal Medical INC.

Qingdao Baheal Medical INC. engages in research and development, production, and sale of pharmaceutical products. The company offers vitamin D calcium chewable tablets. The company was founded in 2005 and is based in Qingdao, China. [Read more]

Sector Healthcare
Founded 2005
Employees 2,642
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301015
Full Company Profile

Financial Performance

In 2023, Qingdao Baheal Medical INC.'s revenue was 7.56 billion, an increase of 0.72% compared to the previous year's 7.51 billion. Earnings were 656.31 million, an increase of 30.71%.

Financial Statements

News

There is no news available yet.